Mission, Vision, Values

Expanding Our Frontiers

At CryoCath, the concept of developing new frontiers is at the core of our corporate culture. It's about the kind of creative thinking that has allowed us to build quickly on a strong technology to deliver products that are helping people lead better lives. It means constantly looking at new ways to use CryoTherapy in the treatment of cardiovascular disease through an aggressive R&D program.

Already successful in major European and Rest-of-World (ROW) markets, we are extending our leadership to the United States through growing sales of Freezor® products. We have established a pre-eminent position in catheter-based CryoTherapy products for the electrophysiology ablation market with Freezor®, Freezor® Xtra and Arctic Front®.

Expanding our frontiers also means constantly expanding our geographical reach to bring our innovations to markets around the globe. But most of all, it means that we work as a team in which every single member is driven by a personal sense of urgency and commitment to deliver results.